Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
02/06/2026 13:04
BRIEF-Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003 June 2 (Reuters) - Enveric Biosciences Inc ENVB.O:
ENVERIC BIOSCIENCES INITIATES INVESTIGATIONAL NEW DRUG (IND)-ENABLING GENOTOXICITY STUDIES OF LEAD NEUROPLASTOGEN CANDIDATE EB-003
ENVERIC BIOSCIENCES - INITIATES IND-ENABLING GENOTOXICITY STUDIES FOR EB-3
Source text: ID:nBw5C6c44a
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003